Back to search
FDAFDA · Food and drugs·Recall number D-1101-2023

AstrinGyn (Ferric Subsulfate) Aqueous, 259 mg/g, 8 gm Single Use Vials, Manufactured for CooperSurgical, Trumbull, CT 06611, NDC 59365-6065-0, Ref 6065.

Published August 30, 2023 · Recall initiated: August 9, 2023

Summary

FDA records drug Class II recall D-1101-2023, published August 30, 2023 and initiated August 9, 2023. Recalling firm: Ecometics, Inc.; Status: Completed; Reported quantity: 92,967 vials; Lot: Lot #: 2E144A, 2E157A, exp: 11/2023; 2E270A, exp: 3/2024; 2E300A, exp: 4/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Products not manufactured under current good manufacturing practices.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Ecometics, Inc.
Distributor
Nationwide in the USA
Lot
Lot #: 2E144A, 2E157A, exp: 11/2023; 2E270A, exp: 3/2024; 2E300A, exp: 4/2024
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was AstrinGyn (Ferric Subsulfate) Aqueous, 259 mg/g, 8 gm Single Use Vials, Manufactured for CooperSurgical, Trumbull, CT 06611, NDC 59365-6065-0, Ref 6065. recalled?

Yes. FDA published recall D-1101-2023 on August 30, 2023. Reported hazard: CGMP Deviations: Products not manufactured under current good manufacturing practices.

What should I do if I have this product?

Voluntary: Firm initiated · Letter